| ID | 62644 |
| FullText URL | |
| Author |
Hagiya, Hideharu
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science
ORCID
Kaken ID
researchmap
Otsuka, Fumio
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science
ORCID
Kaken ID
publons
researchmap
|
| Note | © 2021 Elsevier Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 License.http://creativecommons.org/licenses/by-nc-nd/4.0/.This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.clinthera.2021.07.007] .
|
| Published Date | 2021-07-12
|
| Publication Title |
Clinical Therapeutics
|
| Volume | volume43
|
| Issue | issue9
|
| Publisher | Elsevier Inc.
|
| Start Page | 1622
|
| End Page | 1623
|
| ISSN | 01492918
|
| NCID | AA00143411
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © 2021 Elsevier Inc.
|
| File Version | author
|
| DOI | |
| Related Url | isVersionOf https://doi.org/10.1016/j.clinthera.2021.07.007
|
| License | http://creativecommons.org/licenses/by-nc-nd/4.0/
|
| Citation | Hideharu Hagiya, Fumio Otsuka, Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use, Clinical Therapeutics, 2021, ISSN 0149-2918, https://doi.org/10.1016/j.clinthera.2021.07.007.
|
| Open Access (Publisher) |
non-OA
|
| Open Archive (publisher) |
Non-OpenArchive
|
